Discover 1,776 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
Active & ResponsiveNew
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
for
Influenza, Human
Location: Greensboro NC, Newport News VA, North Charleston SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07121192
Phase2, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
for
Influenza
Location: Winston-Salem NC, Salisbury NC, Durham NC, Charlotte NC,
Sponsor: Cidara Therapeutics Inc.
Sex: All
Age: 12+
Code: NCT07159763
Phase3, Recruiting
Active & ResponsiveNew
Early Intervention to Promote Cardiovascular Health of Mothers and Children
for
Cardiovascular Health
Location: Winston-Salem NC, Pittsburgh PA, State College PA,
Sponsor: JHSPH Center for Clinical Trials
Sex: Female
Age: 18+
Code: NCT06272045
Recruiting
Active & ResponsiveNew
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
for
Obesity, Cancer, Physical Activity, Cancer Survivorship, Diet
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 39
Code: NCT06848491
Recruiting
Active & ResponsiveNew
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
for
Breast Cancer, Breast Neoplasms
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: Female
Age: 20 - 70+
Code: NCT07214610
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
for
Monkeypox (Mpox)
Location: Cary NC
Sponsor: Bavarian Nordic
Sex: All
Age: 18 - 49
Code: NCT07199569
Phase2, Recruiting
Active & Responsive
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis